A health technology assessment of transient elastography in adult liver disease.
about
Imaging Based Methods of Liver Fibrosis Assessment in Viral Hepatitis: A Practical ApproachTransient Elastography for Assessment of Liver Fibrosis and Steatosis: An Evidence-Based Analysis.Transient Elastography and Controlled Attenuation Parameter for Diagnosing Liver Fibrosis and Steatosis in Ontario: An Economic Analysis.Virtual Touch™ Quantification to Diagnose and Monitor Liver Fibrosis in Hepatitis B and Hepatitis C: A NICE Medical Technology GuidanceThe feasibility and reliability of transient elastography using Fibroscan®: a practice audit of 2335 examinationsAn update on the management of chronic hepatitis C: 2015 Consensus guidelines from the Canadian Association for the Study of the Liver.Liver stiffness by transient elastography predicts liver-related complications and mortality in patients with chronic liver disease.Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis.Non-invasive monitoring of liver fibrosis.Systematic review with meta-analysis: the diagnostic accuracy of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B.Transient elastography for the diagnosis of liver fibrosis: a systematic review of economic evaluations.Cost-Effective Evaluation of Nonalcoholic Fatty Liver Disease With NAFLD Fibrosis Score and Vibration Controlled Transient Elastography.Improving access to transient elastography in Canada will need more than evidence-based guidelines and technical health assessment.Hepatitis C virus infection in children and adolescents.Progress in non-invasive detection of liver fibrosis.
P2860
Q26771433-99E520C1-8B18-4CEC-8794-494750343029Q26776180-05B4AFE6-ECA0-47F9-AFAE-01B782730DC9Q28084154-8C8ED3F5-4E25-49E6-B64E-1C8C01D74F4CQ30360732-EA0BCA5A-7642-4FD3-B6A2-2EE5B629CB55Q33810066-F7C948B4-1F21-4021-9F62-B391BF058251Q35100139-CF558C84-6B6E-402A-A983-F2994D197BDAQ35155090-9D04A31F-D82F-4B93-92D4-3DC7BF4FECFDQ35785198-54728D2F-E999-40DF-8D6F-4A8400EF4146Q38262486-928DE9F8-B08A-4BFF-BABA-A03B7FF23451Q38669857-17342C35-C780-4403-8619-22315E6F2048Q38971767-1397D720-9D68-4680-A63C-2990E0385B3BQ41456415-7C149444-BDF0-44BB-9B7F-50A195CF1A26Q43213528-1A6E1FC8-68BA-46F2-881D-94FC7A30B5EEQ54277218-0C0581F2-8039-437E-BD5A-3891D1A70D08Q55421930-4C0B0FCD-F792-4393-AB9C-B3D127BE4EC7
P2860
A health technology assessment of transient elastography in adult liver disease.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A health technology assessment of transient elastography in adult liver disease.
@ast
A health technology assessment of transient elastography in adult liver disease.
@en
type
label
A health technology assessment of transient elastography in adult liver disease.
@ast
A health technology assessment of transient elastography in adult liver disease.
@en
prefLabel
A health technology assessment of transient elastography in adult liver disease.
@ast
A health technology assessment of transient elastography in adult liver disease.
@en
P2093
P2860
P356
P1476
A health technology assessment of transient elastography in adult liver disease.
@en
P2093
Diane Lorenzetti
Fiona Clement
Laura Leggett
Lloyd Sutherland
Robert P Myers
Rodney Steadman
Sarah Rose
Tom Noseworthy
P2860
P304
P356
10.1155/2013/684982
P407
P577
2013-03-01T00:00:00Z